Page 22 - Read Online

10. Feder HM Jr, Johnson BJ, O’Connell S, Shapiro ED, Steere AC, Neurol J 2012;6:79‑87.
Wormser GP; Ad Hoc International Lyme Disease Group, Agger 17. Donta ST, Noto RB, Vento JA. SPECT brain imaging in chronic
WA, Artsob H, Auwaerter P, Dumler JS, Bakken JS, Bockenstedt Lyme disease. Clin Nucl Med 2012;37:e219‑22.
LK, Green J, Dattwyler RJ, Munoz J, Nadelman RB, Schwartz I, 18. Giannopoulos S, Kosmidou M, Sarmas I, Markoula S, Pelidou SH,
Draper T, McSweegan E, Halperin JJ, Klempner MS, Krause PJ, Lagos G, Kyritsis AP. Patient compliance with SSRIs and gabapentin
Mead P, Morshed M, Porwancher R, Radolf JD, Smith RP Jr, Sood in painful diabetic neuropathy. Clin J Pain 2007;23:267‑9.
S, Weinstein A, Wong SJ, Zemel L. A critical appraisal of “chronic 19. Stricker RB, Johnson L. Lyme disease: the next decade. Infect Drug
Lyme disease”. N Engl J Med 2007;357:1422‑30. Resist 2011;4:1‑9.
11. Baker PJ. Perspectives on “chronic Lyme disease”. Am J Med 20. Stricker RB, Johnson L. Searching for autoimmunity in “antibiotic
2008;121:562‑4. refractory” Lyme arthritis. Mol Immunol 2008;45:3023‑4.
12. Cameron DJ, Johnson LB, Maloney EL. Evidence assessments 21. Cruz AR, Moore MW, La Vake CJ, Eggers CH, Salazar JC, Radolf
and guideline recommendations in Lyme disease: the clinical JD. Phagocytosis of Borrelia burgdorferi, the Lyme disease
management of known tick bites, erythema migrans rashes and spirochete, potentiates innate immune activation and induces
persistent disease. Expert Rev Anti Infect Ther 2014;12:1103‑35.
13. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck‑Ytter Y, apoptosis in human monocytes. Infect Immun 2008;76:56‑70.
Alonso‑Coello P, Schünemann HJ; GRADE Working Group. 22. Marques A, Telford SR 3rd, Turk SP, Chung E, Williams C, Dardick
GRADE: an emerging consensus on rating quality of evidence and K, Krause PJ, Brandeburg C, Crowder CD, Carolan HE, Eshoo
strength of recommendations. BMJ 2008;336:924‑6. MW, Shaw PA, Hu LT. Xenodiagnosis to detect Borrelia burgdorferi
14. Fallon BA, Keilp JG, Corbera KM, Petkova E, Britton CB, Dwyer infection: A first‑in‑human study. Clin Infect Dis 2014;58:937‑45.
E, Slavov I, Cheng J, Dobkin J, Nelson DR, Sackeim HA. A 23. Blanc F, GELBY. Neurologic and psychiatric manifestations of
randomized, placebo‑controlled trial of repeated IV antibiotic Lyme disease. Med Mal Infect 2007;37:435‑45.
therapy for Lyme encephalopathy. Neurology 2008;70:992‑1003. 24. Grogan PM, Gronseth GS. Practice parameter: steroids, acyclovir,
15. DeLong AK, Blossom B, Maloney EL, Phillips SE. Antibiotic and surgery for Bell’s palsy (an evidence‑based review): report of
retreatment of Lyme disease in patients with persistent symptoms: the Quality Standards Subcommittee of the American Academy of
a biostatistical review of randomized, placebo‑controlled, clinical Neurology. Neurology 2001;56:830‑6.
trials. Contemp Clin Trials 2012;33:1132‑42. 25. Bentas W, Karch H, Huppertz H. Lyme arthritis in children and
16. Fallon BA, Petkova E, Keilp JG, Britton CB. A reappraisal of the adolescents: outcome 12 months after initiation of antibiotic
U.S. Clinical trials of post‑treatment Lyme disease syndrome. Open therapy. J Rheumatol 2000;27:2025‑30.

Neuroimmunol Neuroinfammation | Volume 3 | Issue 1 | January 20, 2016 13